Intervention Study for the effect of Istradefylline on onset of Dyskinesia in Patients with Parkinson's Disease.

Trial Profile

Intervention Study for the effect of Istradefylline on onset of Dyskinesia in Patients with Parkinson's Disease.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Istradefylline (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms ODYSSEY
  • Most Recent Events

    • 16 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 26 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top